Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Targovishte

12 clinical trials in Targovishte, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Targovishte at a glance
12
clinical trials
  • Not yet recruiting0
  • Research sites1
Type of trial
Recruitment status
Quick filters

12 trials in Targovishte

Open in trial search
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Iti-1284
  • Sponsor:Intra-Cellular Therapies Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:HTL0022537
  • Sponsor:Neurocrine Biosciences Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:(1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
  • Sponsor:Vanda Pharmaceuticals Netherlands B.V.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Iti-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Embolism venous

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Sirius Therapeutics Inc.

Schizophrenia

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Cariprazine
  • Sponsor:Gedeon Richter Plc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Cognitive disorder+1

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:(2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
  • Sponsor:Recognify Life Sciences Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Cariprazine
  • Sponsor:Gedeon Richter Plc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Targovishte

What the registry says about research in the country

01 Mental Health Studies

Comprehensive research focusing on schizophrenia treatment, particularly in adolescent populations, alongside studies examining cognitive impairment associated with the condition.

  • Adolescent Schizophrenia Treatment
  • Cognitive Function Enhancement
  • Long-term Safety Assessments

Multiple trials evaluating new therapeutic approaches and adjunctive treatments for better symptom management.

02 Mood Disorders Research

Innovative studies addressing Major Depressive Disorder and Generalized Anxiety Disorder, testing novel therapeutic compounds for improved treatment outcomes.

  • Depression Management
  • Anxiety Treatment
  • Long-term Effectiveness Studies

Focus on developing adjunctive therapies and evaluating long-term safety profiles of new medications.

03 Metabolic Health

Groundbreaking research in Type 2 Diabetes management, including specialized studies for younger patients and optimization of treatment combinations.

  • Pediatric Diabetes Care
  • Insulin Optimization
  • Weight Management

Innovative approaches to glycemic control in both adult and adolescent populations.

04 Cardiovascular Prevention

Advanced research in atherosclerotic cardiovascular disease prevention, evaluating new therapeutic approaches for high-risk patients.

  • Primary Prevention Strategies
  • Cardiovascular Risk Reduction
  • Long-term Outcomes

Focus on preventing major adverse cardiovascular events through innovative treatments.

05 Autoimmune Conditions

Specialized research examining treatments for Psoriatic Arthritis, with particular attention to axial disease manifestations.

  • Arthritis Management
  • Symptom Reduction
  • Bio-naive Patient Care

Evaluation of targeted therapies for improved patient outcomes in inflammatory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.